Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 18 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
Q3 2023 vs. Q2 2023
How the institutions holding Revolution Medicines, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 139 | 168 | +29 |
| Shares | 112.0M | 112.4M | +450.9K (+0.4%) |
| Value | $2.99B | $3.11B | +$117.1M (+3.9%) |
New holders (42)
Institutions that held Revolution Medicines, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (13)
Institutions that held Revolution Medicines, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Sofinnova Investments, Inc. | 520,377 | $13.9M |
| Polar Asset Management Partners Inc. | 259,700 | $6.95M |
| Maven Securities LTD | 100,000 | $2.67M |
| Trexquant Investment LP | 52,181 | $1.40M |
| Dark Forest Capital Management LP | 23,162 | $619.6K |
| Gsa Capital Partners LLP | 18,762 | $502.0K |
| American Century Companies Inc | 16,135 | $431.6K |
| Tudor Investment Corp Et Al | 13,583 | $363.3K |
| Prelude Capital Management, LLC | 12,100 | $323.7K |
| Los Angeles Capital Management LLC | 11,614 | $310.7K |
| Virginia Retirement Systems Et Al | 10,900 | $291.6K |
| Simplex Trading, LLC | 328 | $8.00K |
| Disciplined Investments, LLC | 2 | $54 |